We are live on
!
Find out more
CPX
Canaan Partners X Portfolio holdings
AUM
$74.7M
1-Year Est. Return
151.56%
This Fund
S&P 500
This Quarter
Est. Return
+64.52%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$155M
AUM Growth
–
Cap. Flow
+$119M
Cap. Flow
% of AUM
76.81%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextCure
NXTC
|
+$94.2M |
| 2 |
IDEAYA Biosciences
IDYA
|
+$19M |
| 3 |
ITRM
Iterum Therapeutics
ITRM
|
+$5.64M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
MIC
KCM
SV
TMC
BS
VCM
JAMONY
JCG
Canaan Partners X's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Canaan Partners X, which disclosed 3 positions worth $155M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is NextCure: 187,870 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Canaan Partners X's largest Q4 2019 buy was NextCure: 187,870 shares worth $127M.
- Canaan Partners X's ten largest holdings make up 100% of its $155M portfolio in Q4 2019.
- Canaan Partners X disclosed 3 positions in Q4 2019, its first 13F filing on record.
Based on Canaan Partners X's 13F filing for Q4 2019, filed 27 Jan 2020.